Swipe om te navigeren naar een ander artikel
We investigate whether cancer patients’ economic characteristics are independent determinants of health-related quality of life (HRQoL) in low- and middle-income settings to identify priorities for health policy and research.
A cross-sectional survey of 9,513 cancer patients from Southeast Asia provided data on demographics, economic status and HRQoL. HRQoL was measured using the EORTC QLQ-C30 and EQ-5D. Information on cancer site and stage was collected using the patients’ medical records. Multiple linear regression analysis estimated the relative impact of economic characteristics (i.e. health insurance, employment status, household income and economic hardship) on HRQoL.
All economic characteristics were significant independent determinants of HRQoL, when we controlled for demographic and clinical characteristics. Economic hardship was found to be most important. The adjusted mean differences in HRQoL scores between patients who had experienced economic hardship in the year before diagnosis compared to patients who did not were −5.6, −6.7, −7.3 and −0.06, respectively, for global health, physical function, emotional function and the EQ-5D index (all p values <0.001). Subgroup analyses showed that this significant result for economic hardship as a predictor of poor HRQoL was consistent across all age groups, for males and females, and across all levels of education.
Living in poor economic circumstances before a cancer diagnosis is associated with greatly impaired HRQoL after diagnosis. There is wide scope for research on innovative interventions that provide low-cost and targeted support aimed to improve health outcomes of disadvantaged cancer patients in low- and middle-income settings.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Stewart, B. W., & Wild, C. P. (2014). World Cancer Report 2014. Lyon: International Agency for Research on Cancer.
Jordan, K., Proskorovsky, I., Lewis, P., Ishak, J., Payne, K., Lordan, N., et al. (2013). Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: Results of a European, multicenter cohort study. Supportive Care in Cancer,. doi: 10.1007/s00520-013-1991-4. PubMedCentral
Vissers, P. A., Thong, M. S., Pouwer, F., Zanders, M. M., Coebergh, J. W., & van de Poll-Franse, L. V. (2013). The impact of comorbidity on Health-Related Quality of Life among cancer survivors: Analyses of data from the PROFILES registry. Journal of Cancer Survivorship, 7(4), 602–613. doi: 10.1007/s11764-013-0299-1. CrossRefPubMed
Saw, Y. M., Win, K. L., Shiao, L. W., Thandar, M. M., Amiya, R. M., Shibanuma, A., et al. (2013). Taking stock of Myanmar’s progress toward the health-related Millennium Development Goals: Current roadblocks, paths ahead. International Journal for Equity in Health, 12, 78. doi: 10.1186/1475-9276-12-78. CrossRefPubMedCentralPubMed
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. CrossRefPubMed
Fayers, P., Aaronson, N., Bjordal, K., & Sullivan, M. (1995). EORTC QLQ-C30 Scoring Manual. EORTC Study Group on Quality of Life.
Cocks, K., King, M. T., Velikova, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30. Journal of Clinical Oncology, 29(1), 89–96. doi: 10.1200/jco.2010.28.0107. CrossRefPubMed
EuroQoL Group. (1990). EuroQol–a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208. CrossRef
Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., et al. (2013). GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer.
Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A. G., Ringash, J., Gotay, C., et al. (2014). A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer, 120(2), 302–311. doi: 10.1002/cncr.28382. CrossRefPubMed
McIntyre, D., Thiede, M., Dahlgren, G., & Whitehead, M. (2006). What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Social Science and Medicine, 62(4), 858–865. doi: 10.1016/j.socscimed.2005.07.001. CrossRefPubMed
Cleary, J., Ddungu, H., Distelhorst, S. R., Ripamonti, C., Rodin, G. M., & Bushnaq, M. A., et al. (2013). Supportive and palliative care for metastatic breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. The Breast, 22(5), 616–627, doi: 10.1016/j.breast.2013.07.052.
Ganz, P. A., Yip, C. H., Gralow, J. R., Distelhorst, S. R., Albain, K. S., & Andersen, B. L., et al. (2013). Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. The Breast, 22(5), 606–615, doi: 10.1016/j.breast.2013.07.049.
- The relationship between economic characteristics and health-related quality of life in newly diagnosed cancer patients in Southeast Asia: results from an observational study
- Springer International Publishing